Sustained virological response with 29 days of Debio 025 monotherapy in hepatitis C virus genotype 3
- PMID: 20966029
- DOI: 10.1136/gut.2010.217323
Sustained virological response with 29 days of Debio 025 monotherapy in hepatitis C virus genotype 3
Comment on
-
New aspects of an anti-tumour drug: sorafenib efficiently inhibits HCV replication.Gut. 2009 Dec;58(12):1644-53. doi: 10.1136/gut.2009.182212. Epub 2009 Aug 25. Gut. 2009. PMID: 19710032
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical